Panbela Therapeutics Inc (PBLA)
0.48
+0.08
(+20.00%)
USD |
OTCM |
May 16, 16:00
Panbela Therapeutics Cash from Financing (Quarterly): 4.749M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.749M |
| September 30, 2023 | -0.019M |
| June 30, 2023 | 7.708M |
| March 31, 2023 | 13.70M |
| December 31, 2022 | 5.349M |
| September 30, 2022 | 0.005M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.001M |
| September 30, 2021 | 9.053M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 1.042M |
| December 31, 2020 | -0.711M |
| September 30, 2020 | 9.359M |
| June 30, 2020 | 1.822M |
| March 31, 2020 | -0.026M |
| December 31, 2019 | -0.061M |
| September 30, 2019 | 3.115M |
| June 30, 2019 | -0.028M |
| March 31, 2019 | 0.758M |
| December 31, 2018 | 1.329M |
| September 30, 2018 | -0.027M |
| June 30, 2018 | 0.73M |
| March 31, 2018 | 1.611M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.04M |
| March 31, 2017 | 3.066M |
| December 31, 2016 | 0.042M |
| September 30, 2016 | 0.27M |
| June 30, 2016 | 1.603M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 1.163M |
| June 30, 2015 | 1.078M |
| March 31, 2015 | 0.434M |
| December 31, 2014 | 0.404M |
| September 30, 2014 | 2.415M |
| June 30, 2014 | -0.0019M |
| March 31, 2014 | -0.0022M |
| December 31, 2013 | -0.0056M |
| September 30, 2013 | -0.0017M |
| June 30, 2013 | -0.0011M |
| March 31, 2013 | -0.0032M |
| December 31, 2012 | -0.0043M |
| September 30, 2012 | -0.0169M |
| June 30, 2012 | 0.0189M |
| March 31, 2012 | 0.0092M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.711M
Minimum
Dec 2020
13.70M
Maximum
Mar 2023
2.898M
Average
0.005M
Median
Sep 2022
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.08M |
| Free Cash Flow | -25.25M |
| Free Cash Flow Per Share (Quarterly) | -6.416 |
| Free Cash Flow Yield | -31.15K% |